Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Earnings Per Share Diluted of $0.00 per share for the year ending 2025.
- This data is from ACRO BIOMEDICAL CO., LTD.'s annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), ACRO BIOMEDICAL CO., LTD.'s Earnings Per Share Diluted has grown by 100.0%.
- Historical annual values: Fiscal year 2025: $0.00 per share | Fiscal year 2024: $0.00 per share | Fiscal year 2023: $0.15 (loss) per share | Fiscal year 2022: $0.26 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: